Dr. Biola M. Javierre receives the PharmaMar Foundation's 2024 Argonauta Award for best young researcher December 10, 2024 Dr. Biola M. Javierre receives the PharmaMar Foundation's 2024 Argonauta Award for best young researcher
The Josep Carreras Institute welcomes Chilean haematologists to a meeting on Acute Leukaemia and Multiple Myeloma May 13, 2024 The Josep Carreras Institute welcomes Chilean haematologists to a meeting on Acute Leukaemia and Multiple Myeloma
The Josep Carreras Institute will present the latest in haematology research in a new international Symposium May 10, 2024 The Josep Carreras Institute will present the latest in haematology research in a new international Symposium
First patient treated in OneChain Immunotherapeutics’ CAR T trial for a rare and aggressive subtype of leukaemia May 07, 2024 First patient treated in OneChain Immunotherapeutics’ CAR T trial for a rare and aggressive subtype of leukaemia
The Josep Carreras Institute brings science closer to hospitalised children April 29, 2024 The Josep Carreras Institute brings science closer to hospitalised children
Vincenzo Calvanese: “I want to know what makes a stem cell… a stem cell” April 11, 2024 Vincenzo Calvanese: “I want to know what makes a stem cell… a stem cell”
The last trick of p53: early 3D chromatin remodelling to trigger cellular stress response April 05, 2024 The last trick of p53: early 3D chromatin remodelling to trigger cellular stress response
The Josep Carreras Leukaemia Research Institute is accredited as a Severo Ochoa Centre of Excellence March 25, 2024 The Josep Carreras Leukaemia Research Institute is accredited as a Severo Ochoa Centre of Excellence
Researchers find the key to genome-modifying drugs sensitivity in malignant blood diseases March 14, 2024 Researchers find the key to genome-modifying drugs sensitivity in malignant blood diseases
The Spanish Association Against Cancer selects five projects from the Josep Carreras Institute for its 2023 Research Grants March 11, 2024 The Spanish Association Against Cancer selects five projects from the Josep Carreras Institute for its 2023 Research Grants
OneChain Immunotherapeutics receives support to advance a new promising CAR T therapy for a rare leukaemia with no therapeutic alternatives March 04, 2024 OneChain Immunotherapeutics receives support to advance a new promising CAR T therapy for a rare leukaemia with no therapeutic alternatives
-edit-20240304133439.jpg?locale=en)